|
|
About_photo

Brad Vince, DO

Vince & Associates Clinical Research
Dr. Vince is the CEO and Medical Director of Vince & Associates Clinical Research (VACR) in Overland Park, Kansas. Dr. Vince founded VACR in 2001, and has led the institution to become a leading independent provider of clinical trials services to the global biopharmaceutical industry. For 15 years, VACR has focused on providing quality research data and exceptional customer service while maintaining the highest ethical and professional standards.

.

.

.

30 Research Presentations

.

40 Scientific Publications

.

Conference Presenter and Co-Chair

.

Publications, Posters and Press

Vince & Associates Clinical Research

Early Development Clinical Research Facility

Vince &Associates Clinical Research was founded by Brad Vince in 2001 and is recognized by the global pharmaceutical and biotech industry as a leading provider of early phase clinical development. Vince & Associates is also recognized as a Center of Research Excellence for its Physician Research Model® of operation.

With fifteen years of research excellence, Vince & Associates focuses on delivering quality research data with speed and accountability, as well as providing comprehensive safety and security features.

The Clinical Pharmacology Research Unit, which opened in 2011, was designed and built to provide the industry with research data that not only allowed for earlier drug development decisions but also advance drugs to the market. The Clinical Pharmacology unit was designed to appear as an upscale, boutique hotel – with accommodations that ensure optimum volunteer recruitment, safety and retention. The 100-bed research unit features 20-inch touch-screen entertainment systems at bedside, allowing study volunteers to watch TV and movies, browse the web or play video games. In addition, the facility has an in-house movie theater and game room. The individually-themed luxury research suites set a new standard in early development trials. The controlled-access unit also features a USP 797-compliant biosafety cabinet and full-time pharmacy staff.

The Clinical Pharmacology Research Unit Expansion, which is scheduled to open in January 2016, will allow Vince & Associates to offer additional specialty services to sponsors. The new unit will feature a specialty unit for early QT evaluation modified to minimize cardiac monitoring interference, a level 5 pharmacy, controlled ventilation smoking rooms, a limited access unit to sequester special populations, expanded recruitment center and additional beds.

Visit Vince & Associates' Website

 

Technology Advancing Clinical Trials

One of the best things about working in the biopharmaceutical industry is the cool technology that we get to see developed every day. We’ve seen...

Read More

A Historical Timeline of Clinical Trials

Like everything it has been a process. Thanks to the research of Dr. Arun Bhatt and his article “Evolution of Clinical Research: A History Before and Beyond James Lind” we have been able to...

Read More

A Heart-Pounding Development in QT Assessment

The Cardiac Safety Research Consortium-FDA study demonstrated that the new cardiac technology allows this assessment to be conducted as early as

Read More

All Blogs

videos

Awards

.
Vince & Associates Clinical Research was awarded six 2015 CRO Leadership Awards for Quality, Productivity, Regulatory and Innovation in three sectors.
. .
Dr. Brad Vince was named as one of the 100 most inspiring people in the life sciences industry by PharmaVOICE Magazine.

contact

10103 Metcalf Ave, Overland Park, KS 66212

(913) 696-1601

bvince@vinceandassociates.com

www.vinceandassociates.com

Your Email (required)

Your Message